At CTS, we understand the impact converting to the Ortho viral marker platform has on your operations. As we get closer to our implementation date of January 11, 2021 we are committed to providing you information as it becomes available.
Package inserts for the new assays are now available. You can review them on the Communications page by clicking this link: Communications,
In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols ...
On July 6, 2018 the FDA released an industry guidance document for transitioning from individual to ...
We have now added a new section called the "Assay History List" to the "At A Gla...
CTS will be transitioning to a new sFTP server for clients who send test request and/or receive...
CTS communications distributed on July 6th and July 20th.In working with Grifols on the availability...
On December 28, 2021, the FDA updated the emergency use authorization (EUA) for COVID-19 conva...